BEST-CLI - search results
If you're not happy with the results, please do another search
Vein mapping rates show no sign of change two years after BEST-CLI, new study...
Vein mapping for lower extremity bypass in patients with chronic limb-threatening ischemia (CLTI) remains unchanged two years after the BEST-CLI, "revealing the difficulty in...
Analysis of BEST-CLI, PREVENT III reveals significant improvement in vein bypass outcomes over 20-year...
A post-hoc comparison of the BEST-CLI and PREVENT III multicenter, prospective, randomized controlled trials (RCTs) aimed at evaluating outcomes of vein bypass in chronic...
Cost-effectiveness outcomes defy expectations in latest BEST-CLI data drop
The open surgical approach will prove to be “slightly superior” to endovascular intervention in terms of cost per life year gained, while the latter...
New study validates BEST-CLI trial results, ‘suggesting generalizability’
A new propensity-matched analysis of more than 1,100 lower extremity revascularization procedures carried out in patients with chronic limb-threatening ischemia (CLTI)—which aimed to help...
SVS leadership and membership integral to ‘far-reaching’ BEST-CLI trial
Support from the Society for Vascular Surgery (SVS) and, later, funding from the SVS Foundation were integral to the BEST-CLI trial, said one of...
BEST-CLI trial spline model analysis breaks new ground in assessing the impact of CKD...
A new analysis of the BEST-CLI trial has produced the first evidence-based glomerular filtration rate (eGFR) value—30 mL/min/1.73 m2—as the cutoff below which patients...
BEST-CLI: Trial results endure in analysis of patients who presented with diabetes
Diabetes affects approximately 70% of patients with chronic limb-threatening ischemia (CLTI) and is associated with more severe presentation, driven mostly by higher rates of...
Smoking: BEST-CLI trial points to protective effect against MALE in those undergoing open bypass...
An analysis of the BEST-CLI randomized controlled trial (RCT) found that smokers with chronic limb-threatening ischemia (CLTI) should be preferentially treated with open bypass...
VQI analysis of CLTI practice following BEST-CLI finds no pick up in bypass rate
A Vascular Quality Initiative (VQI) analysis of evolving practice in the wake of the BEST-CLI trial demonstrated no increase in the rate of surgical...
Sex-based analysis finds BEST-CLI data generalizable to female patients
A new secondary analysis of sex disparities in the best endovascular versus best surgical therapy in patients with critical limb ischemia (BEST-CLI) trial data...
Sex-based analysis finds BEST-CLI data generalizable to female patients
A new secondary analysis of sex disparities in the best endovascular versus best surgical therapy in patients with critical limb ischemia (BEST-CLI) trial data...
BEST-CLI and the BASIL trials: Motion sees audience move in favor of endovascular therapy...
During the 2024 Charing Cross (CX) International Symposium in London, England (April 23–25), a Great Debate that pitted four global peripheral arterial disease (PAD)...
Landmark BEST-CLI trial gains recognition as top cardiovascular advance in 2023
The American Heart Association (AHA) has named the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb ischemia) trial one of...
BEST-CLI: A year down the road
A dedicated session at the 2023 VEITHsymposium (Nov. 14–18) in New York City aimed to unpack the ways in which clinical practice and attitudes...
CLTI: European cohort study provides ‘strong positive evidence’ for surgery over endovascular approach, supporting...
A recently published study has shown that lower limb bypass surgery offered a significantly higher probability of amputation-free survival and wound healing compared with...
VAM 2023 attendees have their say on the impact of BEST-CLI and BASIL-2 trials
As the vascular community continues to unpack the key learnings from two of the biggest trials to date in chronic limb threatening ischemia—BEST-CLI and...
New analysis probes BEST-CLI trial against real-world setting data
A new analysis of chronic limb-threatening ischemia (CLTI) treatment outcomes was presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions...
VAM attendees chime in on BEST-CLI and BASIL-2
VS@VAM journalist Will Date and videographer Jean-Philippe Bensoussan caught some VAM 2023 foot traffic outside the BEST-CLI and BASIL-2: Debate, Analysis and Implementation session...
BEST-CLI investigators implore a move beyond endo vs. open ‘battle’ in the name of...
The principal investigators behind the BEST-CLI trial struck a conciliatory tone during the inaugural Frank J. Veith Distinguished Lecture yesterday morning in which they...
Analyses offer a deeper dive into BEST-CLI trial data
As the vascular community continues to digest key insights from the BEST-CLI randomized controlled trial (RCT), attendees of Plenary Session 3 at the Vascular...
Base revascularization strategy on effectiveness in restoring adequate and durable limb perfusion, BEST-CLI subanalysis...
The results of a subanalysis of the BEST-CLI trial found that patients with chronic limb-threatening ischemia (CLTI) who were deemed suitable for open lower-extremity...
BEST-CLI vs. BASIL-2: Different questions yield different answers
Medical editor Malachi Sheahan III, MD, takes a look at seemingly conflicting results from the landmark BEST-CLI and BASIL-2 trials, and asks what they...
BASIL-2 and BEST-CLI: A tale of two limb trials
Optimal treatment of patients with chronic limb-threatening ischemia (CLTI) has been an ongoing debate within the vascular community, fueled by growing numbers of patients,...
SVS webinar discusses BEST-CLI and early impacts on practice
A recording of the inaugural “SVS Presents” virtual educational session, on the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb...
New analysis of chronic limb-threatening ischaemia patients places BEST-CLI trial into context within real-world...
A new analysis of chronic limb-threatening ischaemia (CLTI) treatment outcomes was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography &...
BEST-CLI: Analysis finds correlation between WIfI stage four CLTI and reports of poorer mental...
The BEST-CLI dataset has revealed a correlation between wounds, ischemia and foot infection (WIfI) stage and poorer quality of life due to mental, rather...
Vascular community starts process of wrestling with findings from BEST-CLI
One of the earliest multispecialty public gatherings of the vascular community following the release of the first results from the BEST-CLI randomized controlled...
BEST-CLI: Optimal medical therapy adherence ‘well below’ recommended level at baseline
A significant proportion of patients enrolled in the BEST-CLI trial did not meet optimal medical therapy (OMT) guideline-based recommendations at the time of their...
First data from BEST-CLI bring surgical bypass into the forefront of discussion for patients...
The first results from the BEST-CLI randomized controlled trial (RCT) of 1,830 patients show that surgical bypass with adequate single-segment great saphenous vein (GSV)...
BEST-CLI attracts $3.3m funding injection to continue data analysis
The Novo Nordisk Foundation has made a $3.3 million contribution toward the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb...
First results from BEST-CLI poised to reveal ‘very low’ quality of life for patients...
An analysis from the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial presented at the 2022 Vascular Annual...
Experiences with the BEST-CLI trial
As the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb ischemia) trial enters its last phase of new patient enrollment,...
We Must Lead on BEST-CLI Trial, Enroll Patients: Dr. Conte
Dr. Michael Conte issued an urgent call Thursday for vascular surgeons to enroll patients in the BEST-CLI Trial, designed to answer this question: What’s...
BEST-CLI: New Initiatives, Upcoming Meetings
A number of new initiatives have recently been incorporated into the Best Endovascular versus best Surgical Therapy in patients with Critical Limb Ischemia (BEST-CLI)...
UPDATE: Enrollment in BEST-CLI study is well underway
In the past few months the BEST-CLI study has continued to energetically enroll patients. More than 100 of the planned 120 trial sites have...
Designated multispecialty CLTI teams may help in amputation fight
Teams formally defined as specializing in chronic limb-threatening ischemia (CLTI) were associated with a decreased risk of major amputation among a subset of BEST-CLI...
Vascular Specialist–June 2025
In this issue:
Helping OBL vascular surgeons fight the squeeze
‘Rise together’: Harris urges unity in Women’s Vascular Summit presidential address
Senior surgeons:...
Vascular Specialist–April 2025
In this issue:
The question of Vascular Surgery Board independence: Federated or free-standing
From Brazil to Baylor: Gustavo Oderich lands at cardiovascular powerhouse
...
2024 in review: Message from the SVS executive director
The Society for Vascular Surgery (SVS) takes a moment to recognize the dedication, achievements and progress made over the past year. In a letter...
The top 10 most popular Vascular Specialist stories of October 2024
In October, the most read stories from Vascular Specialist included a new leadership announcement from the American College of Surgeons (ACS); study results examining a...
The top 10 most popular Vascular Specialist stories of September 2024
In September, the most read stories from Vascular Specialist included a change in leadership for the Midwestern Vascular Surgical Society; study results examining new treatment...
‘Choosing the right devices for the right patients’: Surgeon-scientist secures NIH funding to develop...
Michael Conte, MD, recently used his 2024 Veith Lecture to call on young vascular surgeons on the peripheral arterial disease (PAD) frontlines to drive...
SCOREPAD seeks to address ‘alarmingly high’ mortality in CLTI patients with underlying coronary disease
A new research letter underscores the need to improve long-term survival following lower extremity revascularization for chronic limb-threatening ischemia (CLTI), setting out a randomized...
Vascular surgery trainees face the future armed similarly with both open and endovascular skills
The BEST-CLI trial underscores the importance of ensuring trainee competence in open peripheral revascularization as well as endovascular treatment. Indeed, the trial results have...
Endovascular showdown: CX 2024 sets the stage for BASIL-3 first-time data presentations
At the Charing Cross (CX) Symposium 2024 (23–25 April, London, UK), Andrew Bradbury (University of Birmingham, Birmingham, UK) and the BASIL-3 team of triallists...
The top 10 most popular Vascular Specialist stories of January 2024
In January, the most read stories from Vascular Specialist include a U.S. Aortic Research Consortium analysis of F/BEVAR preoperative risk factors in AAAs/TAAAs; a...
SVS points to 2023 achievements, challenges in coming year
The Society for Vascular Surgery (SVS) reflects on a year marked by notable achievements on multiple fronts. In a communication to members in mid-December,...
The top 10 most popular Vascular Specialist stories of October 2023
Last month, the most popular stories from Vascular Specialist included The Centers for Medicare & Medicaid Services (CMS) confirmation of carotid artery stenting coverage expansion;...
TCT 2023: LIFE-BTK breathes life into drug-eluting resorbable scaffolds in breakthrough for below-the-knee arteries
Results of the LIFE-BTK randomized controlled trial have just been presented at TCT 2023 (Oct. 23–26) in San Francisco. The data show that, in...
When women are PIs: A story foretold on the vascular frontlines
“Multifactorial” issues persist in gender representation in vascular leadership and trial enrollment, leading women vascular surgeons tell Vascular Specialist.
"We would have fewer untoward side...
The numbers are in: VAM 2023 adds up to another SVS classic
Landmark meeting (June 14-17) with nearly 1,400 vascular professionals moves the needle with program innovations, slew of new science and jam-packed agenda.
With more content...
Second edition of VSITE review text released
The second edition of a hit trainee-created textbook primarily aimed at those taking the Vascular Surgery In-Training Exam (VSITE) has hit the shelves.
The Vascular...
The top 10 most popular Vascular Specialist stories of June 2023
Last month, Vascular Specialist garnered readers' attention with an array of commentary on the BEST-CLI and BASIL-2 trials; the medical editor's interview with vascular...
The Big Interview: Pioneering surgeon recounts career as new VAM lectureship is birthed
Vascular Specialist medical editor Malachi Sheahan III, MD, sits down with Frank J. Veith, MD, to discuss his new book, The Medical Jungle, ahead of the...
Vascular Specialist@VAM: Conference Edition 3
In this issue:
BEST-CLI investigators implore a move beyond endo vs. Open ‘battle’ in the name of scientific advance
Presidential address: ‘The annual meeting...
Special VAM session underscores ‘complementary’ nature of open and endovascular strategies in CLTI patients
A dedicated session at VAM 2023 saw speakers and delegates gather to debate, analyse and consider the implementation of the BEST-CLI and BASIL-2 randomized-controlled...
The global burden of CLTI: ESVS President points toward need for new global vascular...
Early-bird VAM 2023 attendees yesterday gained broad insight into the issues facing vascular surgeons around the world, with the tone set from the opening...
‘Nobody believed us’: Vascular giant discusses overcoming skeptics to make specialty-defining breakthroughs
Malachi Sheahan III, MD, Vascular Specialist’s medical editor, speaks to living legend and limb-salvage pioneer Frank J. Veith, MD, on the contents of his...
VAM 2023 beckons
Our annual gathering is almost here. After months of planning, our premiere educational event in vascular surgery, the Vascular Annual Meeting (VAM), opens June...
Vascular Specialist–June 2023 VAM special
In this VAM 2023 preview issue:
The Vascular Annual Meeting (VAM) beckons: "Our annual gathering is almost here. After months of planning, our premiere...
Attendees preparing for VAM 2023 education, networking
More than 880 vascular professionals are preparing to pack their bags in preparation for the 2023 Society for Vascular Surgery (SVS) Vascular Annual Meeting...
BASIL-2 points towards endovascular-first revascularization strategy in CLTI patients
A question from Manj Gohel, MD, from Cambridge University Hospitals in Cambridge, England, on what the 2023 Charing Cross (CX) International Symposium audience should...
VAM educational sessions set to cover gamut of clinical and vascular practice matters
With sessions covering a wide swath of topics important to vascular surgeons, including many proposed by Society for Vascular Surgery (SVS) members themselves, participants...
On 45th anniversary, CX Symposium chairman credits Chicago vascular surgical tandem for enduring success
The occasion of a seminal meeting held in Chicago by former Society for Vascular Surgery (SVS) Presidents John J. Bergan, MD, and James S.T....
SCVS 2023: Endovascular-first or -only approach to all CLTI patients ‘is not evidence-based care’
Michael S. Conte, MD, one of the foremost experts in the field of peripheral arterial disease (PAD), took attendees of the 2023 annual meeting...
VAM 2023: Early-bird registration opens
Meeting registration and hotel reservations opened March 15 for the Society for Vascular Surgery (SVS) 2023 Vascular Annual Meeting (VAM). This year’s premiere educational...
‘SVS Presents’ provides enhanced learning opportunities
The Society for Vascular Surgery (SVS) will debut “SVS Presents” April 12, a monthly webinar series that provides an evening of educational programming for...
More than a research project: The vascular trainee’s role in tackling disparities in peripheral...
One of my earliest clinical experiences with vascular disease was as a high school student shadowing at a busy urban hospital in Detroit. A...
VAM 2023 meeting set to take place as exclusively in-person event
A block party on opening day, session recordings available daily and—of course—the educational and scientific sessions for which the Society for Vascular Surgery’s Vascular...
The top 10 most popular Vascular Specialist stories of January 2023
In January 2023, most popular among the Vascular Specialist readers were several stories from the recent Southern Association for Vascular Surgery meeting, including a report of data shared to demonstrate...
The top 10 most popular Vascular Specialist stories of December 2022
Among the most-read Vascular Specialist stories in December 2022 were the promising results from a postmarket surveillance study of a paclitaxel DCB; the Society...
Corner Stitch: A reflection on 2022…
This month's column chronicles the exciting year we’ve had here at Corner Stitch. As the section editor, I’ve been most proud of the various...
The 10 most popular Vascular Specialist stories of November 2022
Among November's most read Vascular Specialist stories were updates from the BEST-CLI trial in the form of new data and funding; a guest...
SVS 10-year research goals: Why create research priorities?
As was the case with the 2011 set, researchers hope the updated priorities will serve as a starting point to align research efforts within...
Vascular Specialist–December 2022
In this issue:
Women in vascular: Annual summit dedicated to tackling key issues related to women’s vascular health and female workforce seeks to ‘enable...
Diversifying clinical trials: ‘There needs to be some kind of cultural competency’
The COVID-19 pandemic exposed lingering mistrust in the U.S. healthcare system among patients from minority communities as physicians continue to confront the conundrum of...
Vascular Specialist–November 2022
In this issue:
First data from BEST-CLI are revealed at the American Heart Association (AHA) Scientific Sessions (p. 1 and 12–13)
The Society...
Roundtable for treating CLTI: GLASS will make it clear
The final of three roundtables on treating Chronic Limb-threatening Ischemia (CLTI) will cover the Global Limb Anatomic Staging System—GLASS.
The virtual roundtable, on GLASS staging...
CLTI: Translating guidelines into practice
Clinical practice guidelines (CPG) are integral to helping achieve optimal patient care. The Society for Vascular Surgery (SVS) clinical guidelines are evidence-based and the...
The top 10 most popular Vascular Specialist items of June 2022
June's top stories spanned a range of presentations from the 2022 Vascular Annual Meeting (VAM) in Boston (June 15–18), covering topics including burnout...
SCVS 2022: ‘We should not allow our industry relationships influence how we choose to...
Industry players and device makers have helped spark new science and innovation in vascular surgery amid flatlining National Institutes of Health (NIH) funding, but...
Strength in numbers: Global VASCC COVID-19 project helps identify framework to tackle delayed cases
When Robert Cuff, MD, and Max Wohlauer, MD, first launched the Vascular Surgery COVID-19 Collaborative (VASCC) back in the spring of 2020, the pandemic...
CLI at a crossroads: Which direction now?
Vascular surgery once again finds itself at a crossroads, Michael Belkin, MD, chief of the division of vascular and endovascular surgery at Brigham and...
‘Proceed cautiously in use of DCBs in CLTI patients with advanced WIfI stage’
The last several years have seen ongoing controversy and debate about the risks and benefits of paclitaxel-coated devices (PCDs) for patients with peripheral arterial...
Fighting the good fight: The case for multidisciplinary limb salvage in face of increasing...
Dramatic increases in rates of diabetes—particularly among Black females—through 2060 underscore the importance of a multidisciplinary team approach to limb salvage, according to Vincent...
Lessons in PAD care from VA vascular surgeons
The care of patients with peripheral arterial disease (PAD) is challenging and costly. Every practicing vascular surgeon knows that when patients present with ulcerations,...
The benefits of an academic research career in the VA
Every year a number of graduating vascular trainees look for jobs in academic surgery to develop a career as a surgeon-scientist in basic, translational...
Learn Ins and Outs of Launching a Multicenter Clinical Trial
To help SVS members learn the necessary steps of setting up a multicenter clinical research study, this year’s Vascular Annual Meeting offers “The Nuts...
